+39 02 610346.1 - info@newron.com

Investors and Media

Investors and Media

Newron Pharmaceuticals is headquartered in Bresso, Italy and its shares are listed on SIX Swiss Exchange under the ticker symbol NWRN. Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.

 

Newron newssee all

November 14 2017

Newron to Participate in Upcoming Investor Conferences in November and December

November 07 2017

Newron Pharmaceuticals Announces Advisory Board Recommendations and Rett Congress Findings

  

October 25 2017

Newron Pharmaceuticals to Present at European Rett Syndrome Congress and Host Advisory Board Meeting

 

October 06 2017

Newron Pharmaceuticals Supports Rett Syndrome Awareness Month this October

September 26 2017

Newron raises CHF 27.0 Million in a private placement of new shares.

 

Stock information

Download centre

Email alerts

 

 

 

 

 

Upcoming Eventssee all

Global Mizuho Investor Conference (MIC) 2017

December 4-5, 2017 - The Lotte New York Palace, New York, USA

29th Annual Piper Jaffray Healthcare Conference

November 28–29, 2017 - The Lotte New York Palace, New York, USA

German Equity Forum 2017

November, 27-29, 2017 - Frankfurt, Germany